References
- Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138:575–578. doi:https://doi.org/10.1001/jamaophthalmol.2020.1291.
- Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and eye: a review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol. 2021;69:488–509. doi:https://doi.org/10.4103/ijo.IJO_297_21.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:https://doi.org/10.1016/S0140-6736(20)30211-7.
- Tay MZ, Poh CM, Rénia L, et al. The trinity of COVID19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363–374. doi:https://doi.org/10.1038/s41577-020-0311-8.
- Le Balc’h P, Pinceaux K, Pronier C, Seguin P, Tadié J-M, Reizine F. Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients. Crit Care. 2020 Aug 28;24(1):530. doi:https://doi.org/10.1186/s13054-020-03252-3.
- Vinores SA, Wang Y, Vinores MA, et al. Blood–retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strains. J Neuroimmunol. 2001;119(2):175–182. doi:https://doi.org/10.1016/S0165-5728(01)00374-5.
- Parrill A, Tsao T, Dong V, Huy NT. SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients. J Microbiol Immunol Infect. 2021 Feb;54(1):105–108. doi:https://doi.org/10.1016/j.jmii.2020.08.016.
- Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol. 1994;117:663–667. doi:https://doi.org/10.1016/S0002-9394(14)70075-3.
- Schoenberger SD, Kim SJ, Thorne JE, et al. Diagnosis and treatment of acute retinal necrosis. Ophthalmology. 2017;124(3):382–392. doi:https://doi.org/10.1016/j.ophtha.2016.11.007.
- Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11:827. doi:https://doi.org/10.3389/fimmu.2020.00827.
- Wang F, Hou H, Luo Y, et al. The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. 2020;5(10):e137799. doi:https://doi.org/10.1172/jci.insight.137799.
- Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629. doi:https://doi.org/10.1172/JCI137244.
- Wang F, Nie J, Wang H, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis. 2020;221(11):1762–1769. doi:https://doi.org/10.1093/infdis/jiaa150.
- Pebody RG, Andrews N, Brown D, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect. 2004;80(3):185–191. doi:https://doi.org/10.1136/sti.2003.005850.
- Hillenkamp J, Nolle B, Bruns C, et al. Acute retinal necrosis clinical features, early vitrectomy, and outcomes. Ophthalmology. 2009;116:1971–1975. doi:https://doi.org/10.1016/j.ophtha.2009.03.029.
- Meghpara B, Sulkowski G, Kesen MR, et al. Long-term follow-up of acute retinal necrosis. Retina. 2010;30:795–800. doi:https://doi.org/10.1097/IAE.0b013e3181c7013c.
- Gupta A, Dixit B, Stamoulas K, Akshikar R. Atypical bilateral acute retinal necrosis in a coronavirus disease 2019 positive immunosuppressed patient. Eur J Ophthalmol. 2020;112067212097494. doi:https://doi.org/10.1177/1120672120974941.